Andrew Campbell Email

VP, Global Head Program Management . Aprinoia

Current Roles

Employees:
38
Revenue:
$5.9M
About
Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that is based on innovation and scientific rigor and integrity. Our goal is to create novel products to meet critical patient needs, including: 1) Novel imaging-based diagnostic tools to improve the detection of occurrence, progression, and regression of neurological diseases; and 2) Novel therapies to improve the treatment of human neurological conditions.
Aprinoia Address
245 Main Street
null, null
Aprinoia Email

Past Companies

APRINOIA TherapeuticsVice President, Global Head of Program Management
Praxis Precision Medicines, Inc.Program Executive, Psychiatry and Movement Disorders Portfolio at Praxis Precision Medicines, Inc.
Ultragenyx Pharmaceutical Inc.Program Team Lead, Gene Therapy

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.